CUFinder

Gordon Cook

Gordon Cook

University of Leeds

H-index: 81

Europe-United Kingdom

Contact Gordon Cook

About Gordon Cook

Gordon Cook, With an exceptional h-index of 81 and a recent h-index of 51 (since 2020), a distinguished researcher at University of Leeds,

His recent articles reflect a diverse array of research interests and contributions to the field:

Radiocarbon Dates from samples funded by English Heritage between 2003 and 2006

Poems Syndrome and Disease Produced by Other Monoclonal IGs

Determinants of durable humoral and T cell immunity in myeloma patients following COVID‐19 vaccination

Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial

Genomic Classification and Individualized Prognosis in Multiple Myeloma

Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients

Ixazomib-Based Consolidation and Maintenance Prolongs Progression-Free Survival after Salvage Autologous Stem Cell Transplantation (sASCT): Results from Interim Analysis of UK …

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

Gordon Cook Information

University

Position

___

Citations(all)

27584

Citations(since 2020)

11657

Cited By

21268

hIndex(all)

81

hIndex(since 2020)

51

i10Index(all)

458

i10Index(since 2020)

209

Email

University Profile Page

Google Scholar

Top articles of Gordon Cook

Radiocarbon Dates from samples funded by English Heritage between 2003 and 2006

2024/4/28

Peter Marshall
Peter Marshall

H-Index: 16

Christopher Bronk Ramsey
Christopher Bronk Ramsey

H-Index: 57

Gordon Cook
Gordon Cook

H-Index: 44

Poems Syndrome and Disease Produced by Other Monoclonal IGs

2024/4/11

Gordon Cook
Gordon Cook

H-Index: 44

Determinants of durable humoral and T cell immunity in myeloma patients following COVID‐19 vaccination

European Journal of Haematology

2024/4

Gaurav Agarwal
Gaurav Agarwal

H-Index: 15

Nathanael Gray
Nathanael Gray

H-Index: 90

Gordon Cook
Gordon Cook

H-Index: 44

Sarah Mcdonald
Sarah Mcdonald

H-Index: 3

Sarah Gooding
Sarah Gooding

H-Index: 8

Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial

Bone Marrow Transplantation

2024/1/9

Gordon Cook
Gordon Cook

H-Index: 44

Kwee Yong
Kwee Yong

H-Index: 27

Genomic Classification and Individualized Prognosis in Multiple Myeloma

Journal of Clinical Oncology

2024/1/9

Francesco Maura
Francesco Maura

H-Index: 20

Brian Walker
Brian Walker

H-Index: 6

Martin Kaiser
Martin Kaiser

H-Index: 11

Gordon Cook
Gordon Cook

H-Index: 44

Gareth Morgan
Gareth Morgan

H-Index: 11

Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients

Journal of Hepatology

2024/1/1

Jonathan Cook
Jonathan Cook

H-Index: 16

Palak Trivedi
Palak Trivedi

H-Index: 26

Paul Klenerman
Paul Klenerman

H-Index: 68

Susanna Dunachie
Susanna Dunachie

H-Index: 29

Pietro Lampertico
Pietro Lampertico

H-Index: 36

Francesco Paolo Russo
Francesco Paolo Russo

H-Index: 15

Eleanor Barnes
Eleanor Barnes

H-Index: 44

Ixazomib-Based Consolidation and Maintenance Prolongs Progression-Free Survival after Salvage Autologous Stem Cell Transplantation (sASCT): Results from Interim Analysis of UK …

Blood

2023/11/28

Gordon Cook
Gordon Cook

H-Index: 44

Kwee Yong
Kwee Yong

H-Index: 27

Kevin Boyd
Kevin Boyd

H-Index: 7

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

2023/6/1

Evangelos Terpos
Evangelos Terpos

H-Index: 61

Niels Van De Donk
Niels Van De Donk

H-Index: 40

Michel Delforge
Michel Delforge

H-Index: 40

Kwee Yong
Kwee Yong

H-Index: 27

Gordon Cook
Gordon Cook

H-Index: 44

Meral Beksac
Meral Beksac

H-Index: 42

Mario Boccadoro
Mario Boccadoro

H-Index: 58

Ultra High-Risk Multiple Myeloma Patients with Multi-Hit Tumours and SKY92 High Risk Signature Are at Increased Risk of Early Relapse Even When Treated with Extended …

Blood

2023/11/28

Andrew Hall
Andrew Hall

H-Index: 15

Graham Jackson
Graham Jackson

H-Index: 14

Gordon Cook
Gordon Cook

H-Index: 44

Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

2023/6

Evangelos Terpos
Evangelos Terpos

H-Index: 61

Michel Delforge
Michel Delforge

H-Index: 40

Gordon Cook
Gordon Cook

H-Index: 44

Mario Boccadoro
Mario Boccadoro

H-Index: 58

Health-Related Quality of Life (HRQoL) in Fit, Unfit and Frail Patients Enrolled in Fitness (UK-MRA Myeloma XIV): A Cross Sectional Study

Blood

2023/11/28

Orla Mccourt
Orla Mccourt

H-Index: 4

David Meads
David Meads

H-Index: 27

Graham Jackson
Graham Jackson

H-Index: 14

Gordon Cook
Gordon Cook

H-Index: 44

Immune responses to COVID‐19 booster vaccinations in intensively anti‐CD38 antibody treated patients with ultra‐high‐risk multiple myeloma: results from the Myeloma UK (MUK …

British Journal of Haematology

2023/6

Andrew Hall
Andrew Hall

H-Index: 15

Sarah Brown
Sarah Brown

H-Index: 2

Zania Stamataki
Zania Stamataki

H-Index: 17

Gordon Cook
Gordon Cook

H-Index: 44

P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE …

HemaSphere

2023/5/1

High Success Rates Utilizing Local Standard of Care Cytogenetic Testing for Risk Stratified Frontline Therapy for Newly Diagnosed Multiple Myeloma: Experience from the Ukmra …

Blood

2023/11/28

Sarah Gooding
Sarah Gooding

H-Index: 8

Gordon Cook
Gordon Cook

H-Index: 44

David Meads
David Meads

H-Index: 27

Graham Jackson
Graham Jackson

H-Index: 14

Dean Smith
Dean Smith

H-Index: 13

Kwee Yong
Kwee Yong

H-Index: 27

Dynamic Frailty Assessment in Transplant Non-Eligible Newly Diagnosed Myeloma Patients: Initial Data from UK Myeloma Research Alliance (UK-MRA) Myeloma XIV (FiTNEss): A Frailty …

Blood

2023/11/2

Gordon Cook
Gordon Cook

H-Index: 44

David Meads
David Meads

H-Index: 27

Graham Jackson
Graham Jackson

H-Index: 14

Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real‐world multicentre UK retrospective analysis

British Journal of Haematology

2023/5

Gordon Cook
Gordon Cook

H-Index: 44

Danish Memon
Danish Memon

H-Index: 11

Kwee Yong
Kwee Yong

H-Index: 27

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry

2023/10/18

Martin Kaiser
Martin Kaiser

H-Index: 11

Gordon Cook
Gordon Cook

H-Index: 44

David Cairns
David Cairns

H-Index: 17

Gareth Morgan
Gareth Morgan

H-Index: 11

Graham Jackson
Graham Jackson

H-Index: 14

Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial

Blood

2023/4/6

Gordon Cook
Gordon Cook

H-Index: 44

Kevin Boyd
Kevin Boyd

H-Index: 7

Graham Jackson
Graham Jackson

H-Index: 14

Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study

Insights into Imaging

2023/10/15

Amy Davis
Amy Davis

H-Index: 4

Gordon Cook
Gordon Cook

H-Index: 44

Sarah Brown
Sarah Brown

H-Index: 2

Martin Kaiser
Martin Kaiser

H-Index: 11

Individualized risk stratification in newly diagnosed multiple myeloma

Cancer Research

2023/4/4

Francesco Maura
Francesco Maura

H-Index: 20

Brian Walker
Brian Walker

H-Index: 6

Graham Jackson
Graham Jackson

H-Index: 14

Martin Kaiser
Martin Kaiser

H-Index: 11

Gordon Cook
Gordon Cook

H-Index: 44

Gareth Morgan
Gareth Morgan

H-Index: 11

See List of Professors in Gordon Cook University(University of Leeds)